Pharmaceutical

Trump 2.0 spells global change in pharmaceutical regulation, funding and investment

Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.

Nov 29, 2024 - 06:00
Trump 2.0 spells global change in pharmaceutical regulation, funding and investment
Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.
Read the original article

Tags:

Previous Article

Formosa and Medvisis agree on post-operative eye pain therapy

Next Article

Advanz Pharma’s liver disease drug pulled from European market after court hearing

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Celltrion’s SteQeyma receives EC approval for chronic inflammatory diseases

Celltrion’s SteQeyma receives EC approval for chronic i...

Aug 27, 2024

Mandy Cohen, seen as next CDC director, would bring political chops to an agency lacking them

Mandy Cohen, seen as next CDC director, would bring pol...

Jun 16, 2023

Sandoz partners with Samsung Bioepis to license Stelara biosimilar

Sandoz partners with Samsung Bioepis to license Stelara...

Sep 11, 2023